Vectormune HVT LT at least 3160 PFU/dose ; Formulation: Each 0.05 mL (In-Ovo) or 0.2 mL (SC) (dose) contains: Fowl Laryngotracheitis-Marek's Disease Virus min 3,160 PFU* Suspension for Injection (In-Ovo/SC)
Country: Philippines
Language: English
Source: FDA (Food And Drug Administration)
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
Recombinant Live Fowl Laryngotracheitis (ILT)-Marek's Disease Virus (MDV) Vaccine (Vet.)
Available from:
Ceva Animal Health (Philippines), Inc.; Distributor: Ceva Animal Health (Philippines), Inc.
INN (International Name):
Recombinant Live Fowl Laryngotracheitis (ILT)-Marek's Disease Virus (MDV) Vaccine (Vet.)
Dosage:
at least 3160 PFU/dose ; Formulation: Each 0.05 mL (In-Ovo) or 0.2 mL (SC) (dose) contains: Fowl Laryngotracheitis-Marek's Disease Virus min 3,160 PFU*
Pharmaceutical form:
Suspension for Injection (In-Ovo/SC)
Units in package:
Type I Glass Ampoule x 1,000 doses, 2,000 doses and 4,000 doses + PVC Bag x 200 mL, 400 mL and 800 mL (Box of l’s)
Manufactured by:
Biomune Company, U.S.A.
Authorization date:
2021-11-17
